| Li, Yan |
NCT04035824: Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study |
|
|
| Completed | 4 | 605 | RoW | Gastrodia and Uncaria granule, Placebo of Gastrodia and Uncaria granule | Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Hypertension | 04/24 | 04/24 | | |
NCT05089448: Morning Versus Bedtime Dosing of Antihypertensive Medication |
|
|
| Recruiting | 4 | 300 | RoW | Alisartan, Amlodipine besylate | Yan Li | Hypertension, Blood Pressure, Drug Use | 06/26 | 09/26 | | |
NCT03825692: International Clinical Study of Zhizhu Kuanzhong Capsule |
|
|
| Recruiting | 4 | 480 | RoW | Zhizhu Kuanzhong Capsule, ZZKZ capsule, Zhizhu Kuanzhong Placebo Capsule, placebo | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Functional Dyspepsia, Postprandial Distress Syndrome | 12/23 | 12/23 | | |
| Completed | 3 | 1177 | Europe, Canada, Japan, US, RoW | Mirikizumab SC, LY3074828, Mirikizumab IV, Placebo SC | Eli Lilly and Company | Ulcerative Colitis | 11/21 | 12/24 | | |
|
|
NCT04078568: Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease |
|
|
| Active, not recruiting | 3 | 3208 | RoW | IVIG, Intravenous Immunoglobulins, Human, Aspirin, Acetylsalicylic acid, Prednisolone, STEROLONE | Children's Hospital of Fudan University, Jiangxi Province Children's Hospital, First People's Hospital of Hangzhou, Shengjing Hospital, The First Hospital of Jilin University, Chengdu Women's and Children's Central Hospital, Children's Hospital of Chongqing Medical University, Inner Mongolia People's Hospital, Sichuan Provincial People's Hospital, Wuhan Union Hospital, China, Third Affiliated Hospital of Zhengzhou University, Children's Hospital of Soochow University, Yuying Children's Hospital of Wenzhou Medical University, Beijing Children's Hospital, Qilu Hospital of Shandong University | Kawasaki Disease | 12/24 | 12/25 | | |
| Active, not recruiting | 3 | 404 | Europe, Canada, Japan, US, RoW | Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo | Chinook Therapeutics, Inc. | IgA Nephropathy, Immunoglobulin A Nephropathy | 12/26 | 12/26 | | |
NCT05433480: A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer |
|
|
| Active, not recruiting | 3 | 274 | RoW | BPI-16350, placebo, Fulvestrant | Betta Pharmaceuticals Co., Ltd. | Breast Cancer | 12/23 | 07/25 | | |
nAMD, NCT05461339: TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration |
|
|
| Active, not recruiting | 3 | 488 | RoW | TAB014 Monoclonal Antibody Injection, TAB014, Ranibizumab Injection [Lucentis], Lucentis | TOT Biopharm Co., Ltd., Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Neovascular Age-related Macular Degeneration | 09/24 | 02/25 | | |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
QWINT-2, NCT05362058: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time |
|
|
| Completed | 3 | 928 | Europe, Canada, Japan, US, RoW | Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Degludec | Eli Lilly and Company | Diabetes, Type 2 Diabetes | 04/24 | 04/24 | | |
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa |
|
|
| Recruiting | 3 | 1680 | RoW | Tranexamic acid, 0.9% sodium chloride | Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital | Hemorrhage, Postpartum, Placenta Previa | 02/25 | 04/25 | | |
NCT04578613: ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL |
|
|
| Recruiting | 3 | 218 | RoW | ICP-022, Chlorambucil, Rituximab | Beijing InnoCare Pharma Tech Co., Ltd. | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 12/24 | 06/25 | | |
| Active, not recruiting | 3 | 15374 | Europe, Canada, Japan, US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Overweight | 10/27 | 10/27 | | |
NCT06083623: A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants |
|
|
| Not yet recruiting | 2b | 2250 | RoW | TNM001, placebo | Zhuhai Trinomab Pharmaceutical Co., Ltd. | Respiratory Syncytial Virus Infections | 05/26 | 08/26 | | |
NCT04405154: A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer |
|
|
| Not yet recruiting | 2 | 32 | NA | Camrelizumab, SHR-1210, Cisplatin, Platinol, IMRT or VMAT | West China Hospital | Head and Neck Neoplasms | 05/23 | 05/25 | | |
NCT05299697: A Study of TG103 Injection in Overweight or Obesity |
|
|
| Recruiting | 2 | 195 | RoW | TG103 15 mg, TG103 22.5 mg, Placebo | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Overweight or Obesity | 06/23 | 09/23 | | |
NCT06206720: A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV |
|
|
| Recruiting | 2 | 60 | RoW | Deuremidevir Hydrobromide for Suspension, VV116, Placebo, VV116 placebo | Vigonvita Life Sciences | Respiratory Syncytial Virus Infection | 01/25 | 01/25 | | |
NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus |
|
|
| Not yet recruiting | 2 | 318 | RoW | HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Type 2 Diabetes | 04/25 | 04/25 | | |
| Active, not recruiting | 2 | 103 | Europe, US, RoW | Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627 | Novartis Pharmaceuticals | IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Immunoglobulin A Nephropathy | 07/24 | 07/26 | | |
SKB264-II-04, NCT05816252: A Study of SKB264 for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) |
|
|
| Recruiting | 2 | 498 | Europe, RoW | SKB264, MK-2870, Pembrolizumab, MK-3475, Carboplatin, Carboplatin for injection, Osimertinib, Osimertinib Mesylate | Klus Pharma Inc., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Non-small Cell Lung Cancer | 12/25 | 10/26 | | |
NCT05879055: A Study of PM8002 in Combination With Chemotherapy in Patients With NEN |
|
|
| Recruiting | 2 | 60 | RoW | PM8002, FOLFIRI | Biotheus Inc. | Neuroendocrine Neoplasm | 01/27 | 01/28 | | |
NCT06106841: TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL) |
|
|
| Recruiting | 1/2 | 39 | RoW | 400mg of TQB3909 tablets, 600mg of TQB3909 tablets | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Mantle Cell Lymphoma | 12/24 | 12/24 | | |
NCT06052813: A Study of BN104 in the Treatment of Acute Leukemia |
|
|
| Recruiting | 1/2 | 90 | RoW | BN104 | BioNova Pharmaceuticals (Shanghai) LTD. | ALL, Adult, AML, Adult | 06/26 | 06/27 | | |
NCT05056389: Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA) |
|
|
| Recruiting | 1 | 20 | Europe | Oxaliplatin, Intraperitoneal catheter | Oslo University Hospital | Peritoneal Metastases, Colo-rectal Cancer | 03/23 | 06/23 | | |
| Recruiting | 1 | 76 | RoW | HS-10380, Placebo | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Schizophrenia | 06/23 | 07/23 | | |
NCT06594315: Assessing Brain Metabolism Using MRS With Deuterated Glucose |
|
|
| Active, not recruiting | N/A | 80 | US | Deuterated Glucose, Hydrogen gas (H2) glucose, [6,6'-2H2] glucose, Magnetic Resonance Imaging (MRI), MRI, Blood Sample, MR spectroscopy (MRS), MRS | University of California, San Francisco | Glioma | 07/27 | 07/27 | | |
NCT06610604: Health-Related Quality of Life and Emotions in Patients with Thyroid Nodules |
|
|
| Recruiting | N/A | 500 | RoW | thermal ablation, thyroidectomy | Ming-an Yu | Thyroid Nodule | 06/27 | 12/27 | | |
NCT05258461: An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy |
|
|
| Not yet recruiting | N/A | 108 | NA | use of a smartphone app for adverse event management, conventional adverse event management | Peking Union Medical College Hospital | Breast Cancer | 10/22 | 12/22 | | |
NCT03547856: A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients" |
|
|
| Recruiting | N/A | 10000 | RoW | | Yan Li | Hypertension, Blood Pressure, Cardiovascular Diseases | 09/26 | 12/26 | | |
ASORPWICE, NCT03521739: Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events |
|
|
| Recruiting | N/A | 100000 | RoW | | Chinese Academy of Medical Sciences, Fuwai Hospital | Blood Pressure, Pulse Wave Analysis, Ankle Brachial Index, Patient Outcome Assessment | 12/22 | 12/23 | | |
| Recruiting | N/A | 4500 | RoW | | Shanghai Institute of Hypertension | Nocturnal Hypertension | 09/26 | 12/26 | | |
PROMISE, NCT04135911: A Prospective Study on The"Management of Hypertension in Young and Middle-aged Subjects in Enterprises Setting" |
|
|
| Suspended | N/A | 2000 | RoW | | Yan Li | Hypertension, Blood Pressure | 03/26 | 03/26 | | |
NCT05535400: Effects of Physical-Psychological Integrative Intervention on SCI Patient: a Pilot Randomized Controlled Trial |
|
|
| Completed | N/A | 72 | RoW | Physical-Psychological Integrative Intervention, Brief online didactic education | The Hong Kong Polytechnic University | Spinal Cord Injuries, Physical Inactivity, Depression, Chronic Pain | 12/22 | 07/23 | | |
| Recruiting | N/A | 60 | US | | Oregon Health and Science University, National Eye Institute (NEI) | Fuchs Dystrophy, Pseudophakic Bullous Keratopathy | 06/26 | 06/26 | | |
NCT05558657: Effect of Acupressure on Constipation in Community-dwelling Spinal Cord Injury Patients: a Randomized Controlled Trial |
|
|
| Completed | N/A | 80 | RoW | Home-based, acupressure combined with nursing education, Home-based, manual light touch of the abdomen combined with nursing education | The Hong Kong Polytechnic University | Spinal Cord Injuries, Traditional Chinese Medicine | 09/24 | 09/24 | | |
NCT05531058: The Impact of a Web-based Psychoeducation Programme With a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy |
|
|
| Completed | N/A | 168 | RoW | AI-driven Vaccine Communicator, Self-learning of COVID-19 vaccine knowledge | The Hong Kong Polytechnic University | Vaccine Hesitancy, COVID-19 | 06/24 | 06/24 | | |
NCT01243931: Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy |
|
|
| Recruiting | N/A | 80 | US | OCT-guided laser phototherapeutic keratectomy, Manufacturer/Name OCT Technology 510(K), Optovue/RTVue-CAM Fourier-domain K071250, Bioptigen/Bioptigen Fourier-domain K063343, Zeiss/Visante Time-domain K051789 | Oregon Health and Science University, National Eye Institute (NEI) | Corneal Opacity | 12/26 | 12/26 | | |
NCT02109471: Observational Study of Corneal Opacities in Adults |
|
|
| Recruiting | N/A | 150 | US | | Oregon Health and Science University, National Eye Institute (NEI) | Corneal Opacities (Scar and Stromal Dystrophy) | 12/25 | 12/25 | | |
| Recruiting | N/A | 75 | US | | Oregon Health and Science University | Uveitis | 12/25 | 12/25 | | |
NCT06306378: The Relationship Between Social Memory Disorders and Sleep Spindles in Children With Autism Spectrum Disorder |
|
|
| Recruiting | N/A | 60 | RoW | social memory levels and spindle levels | First Affiliated Hospital Xi'an Jiaotong University, Xi'an TCM Hospital of Encephalopathy | Autism Spectrum Disorder | 03/24 | 04/24 | | |
| Recruiting | N/A | 445 | US | Optical Coherence Tomography | Oregon Health and Science University | Keratoconus, Corneal Opacity, Corneal Dystrophy | 04/25 | 04/26 | | |
| Active, not recruiting | N/A | 60 | US | SKY Breath Intervention | University of California, San Francisco | Depression, Anxiety Disorders | 04/25 | 12/25 | | |
OCT IOL, NCT00532051: Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography |
|
|
| Recruiting | N/A | 690 | US | OCT measurements, Manufacturer/Name OCT Technology 510(K), Optovue/RTVue-CAM Fourier-domain K071250, Bioptigen/Bioptigen Fourier-domain K063343, Zeiss/Visante Time-domain K051789 | Oregon Health and Science University, National Eye Institute (NEI) | Cataract | 07/26 | 07/26 | | |
NCT06686134: Comprehensive Clinical Evaluation Study of GLP-1RA |
|
|
| Recruiting | N/A | 492 | RoW | | LI YAN | T2DM | 12/25 | 07/26 | | |
| Active, not recruiting | N/A | 482 | RoW | | Takeda | Multiple Myeloma, Neoplasms, Plasma Cell | 09/25 | 09/25 | | |
TEAS/ASD, NCT06763237: Abdominal Transcutaneous Electrical Acupoint Stimulation on Children With Autism Spectrum Disorder |
|
|
| Not yet recruiting | N/A | 42 | RoW | abdominal transcutaneous electrical acupoint stimulation (abdominal TEAS), TEAS, Applied Behavior Analysis (ABA) therapy | First Affiliated Hospital Xi'an Jiaotong University, Xian Children's Hospital | Autism Spectrum Disorder, Autism in Children | 01/26 | 01/26 | | |
NCT05282095: Effect of HPV Integration on Prognosis of Young Women With CIN2 in China |
|
|
| Recruiting | N/A | 300 | RoW | Follow up | Fujian Maternity and Child Health Hospital | Cervical Intraepithelial Neoplasia, HPV Infection, Virus Integration, HSIL, High Grade Squamous Intraepithelial Lesions | 12/25 | 05/26 | | |
| Recruiting | N/A | 300 | RoW | Diagnostic biomarker | Shixuan Wang | Uterine Sarcoma | 11/25 | 11/25 | | |
| Recruiting | N/A | 258 | US | | Oregon Health and Science University, National Eye Institute (NEI) | Keratoconus, Irregular; Contour of Cornea | 12/25 | 12/26 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
| Recruiting | N/A | 287 | Europe | Surgical treatment, Non-surgical treatment | Kolding Sygehus, Copenhagen University Hospital, Hvidovre, Zealand University Hospital, Oslo University Hospital, Helse Stavanger HF, Sahlgrenska University Hospital, Sweden, Uppsala University Hospital, Odense University Hospital, Hospital of Southern Jutland, Slagelse Hospital, Aalborg University Hospital, University Hospital, Umeå, Nordsjaellands Hospital, Holbaek Sygehus, Aarhus University Hospital, Copenhagen University Hospital, Herlev-Gentofte, University Hospital Bispebjerg and Frederiksberg, Viborg Regional Hospital, Karolinska University Hospital, Danderyd Hospital, Tampere University Hospital, Helsinki University Central Hospital | Fracture Humerus of Shaft | 12/25 | 07/31 | | |
NCT05858944: Home Blood Pressure Intervention in the Community Trial |
|
|
| Recruiting | N/A | 10000 | RoW | Intensive Home BP control, Home BP<125/75 mmHg, Standard Home BP control, Home BP<135/85 mmHg | Shanghai Institute of Hypertension | Home Blood Pressure | 12/29 | 06/30 | | |
| Recruiting | N/A | 450 | RoW | Healthy control specimen collection, Non-Borrmann IV patient specimen collection, Borrmann IV patient specimen collection | First Hospital of China Medical University, Liaoning Cancer Hospital & Institute, The Second Hospital of Shandong University, The General Hospital of Fushun Mining Bureau, The fourth People's Hospital of Changzhou, The First People's Hospital of Jingzhou | Stomach Neoplasms, Gut Microbiota, Metabolomics | 01/24 | 12/25 | | |
| Recruiting | N/A | 500 | RoW | YISAIPU® ( An etanercept biosimilar), a recombinant tumor necrosis factor receptor-Fc fusion protein, rhTNFR:Fc, csDMARDs | The First Affiliated Hospital of Xiamen University | Rheumatoid Arthritis | 06/25 | 12/25 | | |
| Wang, Ling |
NCT03837873: DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma |
|
|
| Recruiting | 2 | 118 | RoW | Rituximab, Etoposide, Vincristine, Doxorubicin, Dexamethasone, Cyclophosphamide, Lenalidomide, Cisplatin, Cytarabine | Institute of Hematology & Blood Diseases Hospital | Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma | 09/23 | 09/24 | | |
NCT05392257: Efficacy and Safety of Rituximab Plus Zanubrutinib and Lenalidomide for Relapsed and Refractory Diffuse Large B Cell Lymphoma, a Multicenter, Open and Prospective Clinical Trial |
|
|
| Recruiting | 2 | 20 | RoW | Rituximab + zanubrutinib + lenalidomide | Qingdao Central Hospital | Overall Survival | 05/24 | 05/24 | | |
TQB3702-II-02, NCT06566586: A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma |
|
|
| Recruiting | 2 | 80 | RoW | TQB3702 tablets+Chemotherapy regimen | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | B-cell Lymphoma | 03/26 | 12/27 | | |
NCT05870995: Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia |
|
|
| Recruiting | 2 | 100 | RoW | CALGE-VEN- RIC-conditioning | Shanghai Jiao Tong University School of Medicine | Refractory Leukemia | 02/26 | 09/26 | | |
NCT05623982: Phase Ib/II Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma |
|
|
| Recruiting | 1/2 | 40 | RoW | GNC-038 | Sichuan Baili Pharmaceutical Co., Ltd., SystImmune Inc., Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. | Non-hodgkin's Lymphoma | 06/25 | 12/25 | | |
| Recruiting | N/A | 3000 | RoW | | Beijing Jishuitan Hospital | Hip Fractures, Osteoporosis | 05/22 | 11/22 | | |
| Recruiting | N/A | 30000 | RoW | | Beijing Jishuitan Hospital, Chinese PLA General Hospital, Ruijin Hospital, Huashan Hospital, Henan Provincial People's Hospital, The Affiliated Hospital Of Guizhou Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital Xi'an Jiaotong University, The renmin hospital of wuhan university, Nanjing BenQ Hospital, China-Japan Friendship Hospital, xinan hospital, Wu Hu Yijishan hospital, The fifth affiliated hospital of zhong shan university | Osteoporosis, Obesity, Liver Steatoses | 06/23 | 12/23 | | |
| Xiong, Lize |
NCT06030804: Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery |
|
|
| Recruiting | N/A | 4532 | RoW | Dexmedetomidine, Dexmedetomidine hydrochloride, Placebo, Normal saline | Peking University First Hospital, Peking University | Elderly, Cancer Surgery, Dexmedetomidine, Long-Term Survivors | 09/25 | 10/28 | | |
| Wang, Qiang |
NCT05406102: Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy |
|
|
| Not yet recruiting | 4 | 300 | RoW | Remimazolam, experimental, Propofol group, active comparator | First Affiliated Hospital Xi'an Jiaotong University | Anesthetics, Recovery, Drug Effect, Safety, Psychotropic Drugs, Anesthetics, Intravenous | 05/23 | 06/23 | | |
NCT06301854: Long-term Safety of TPN171H Tablet in Erectile Dysfunction. |
|
|
| Recruiting | 3 | 472 | RoW | TPN171H, Simmerafil | Vigonvita Life Sciences | Erectile Dysfunction | 04/25 | 04/25 | | |
NCT06082440: Study on the Safety and Tolerance of Mesenchymal Stem Cells Mediated by Arthroscopy in Patients With Osteoarthritis |
|
|
| Recruiting | 1 | 18 | RoW | Human Umbilical Mesenchymal Stem Cells | First Affiliated Hospital of Wannan Medical College | Osteoarthritis, Knee | 08/25 | 01/26 | | |
| Not yet recruiting | N/A | 10 | RoW | Using robot system of endotracheal intubation and airway cleaning | First Affiliated Hospital Xi'an Jiaotong University | General Anesthesia | 08/20 | 12/23 | | |
NCT06768008: An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease |
|
|
| Recruiting | N/A | 10000 | RoW | | Beijing Anzhen Hospital, Capital Institute of Pediatrics, China, 307 Hospital of PLA | Congenital Heart Disease, Coarctation of Aorta, Aortic Stenosis, Pulmonary Atresia, Pulmonary Stenosis, Transposition of the Great Arteries, Truncus Arteriosus, Single Ventricle, Tetralogy of Fallot (TOF), Interrupted Aortic Arch, Hypoplastic Left Heart Syndrome (HLHS), Total Anomalous Pulmonary Venous Connection | 12/30 | 12/30 | | |
NCT04547296: Sodium Bicarbonate Ringer's Solution for Preventing and Treating Hyperlactacidemia During Hepatectomy |
|
|
| Recruiting | N/A | 484 | RoW | Sodium Bicarbonate Ringer's Solution, Acetate Ringer's Solution | First Affiliated Hospital Xi'an Jiaotong University, Henan Provincial People's Hospital, Henan Cancer Hospital, LanZhou University, Affiliated Hospital of Qinghai University, Shaanxi Provincial People's Hospital, First Affiliated Hospital of Xinjiang Medical University, People's Hospital of Xinjiang Uygur Autonomous Region | Hyperlactacidemia | 10/22 | 03/23 | | |
NCT05530629: Effect of Resistance Training on Energy Intake and Appetite Regulation, 12-weeks Resistance Training |
|
|
| Enrolling by invitation | N/A | 72 | RoW | resistance training, Normal P.E. course | Universiti Putra Malaysia | Overweight, Obese | 10/22 | 12/23 | | |
NCT05613491: Intranasal Insulin Improves Postoperative Neurocognitive Disorders in Elderly Patients |
|
|
| Recruiting | N/A | 438 | RoW | Intranasal insulin, Insulin injection，H10890001,Jiangsu Wanbang Biochemical Medicine Group Co., Ltd, Intranasal saline, 0.9% sodium chloride，H20013250,Shanghai Baite Medical Supplies Co., Ltd | First Affiliated Hospital Xi'an Jiaotong University, Tang-Du Hospital, Tongji Hospital, Second Hospital of Shanxi Medical University, LanZhou University, Sichuan Provincial People's Hospital, The First Affiliated Hospital of Zhengzhou University, 521 Hospital of NORINCO Group | Postoperative Neurocognitive Disorders | 07/23 | 08/23 | | |
NCT05980728: Connective Tissue Disease Patients With Pulmonary Hypertension |
|
|
| Not yet recruiting | N/A | 500 | NA | No Intervention | The First Affiliated Hospital with Nanjing Medical University | Connective Tissue Diseases, Pulmonary Hypertension | 09/27 | 09/30 | | |
| DONG, Hailong |
NCT06145347: Correlation Between Preoperative NT-proBNP and Postoperative AKI |
|
|
| Completed | N/A | 629 | RoW | | Xijing Hospital | Acute Kidney Injury | 07/24 | 07/24 | | |
| Li, Chengxiang |
| Completed | N/A | 980 | RoW | Rotational Atherectomy | Beijing Anzhen Hospital, BSC International Medical Trading (Shanghai) Co., Ltd. | Coronary Artery Disease | 12/20 | 01/22 | | |
| Not yet recruiting | N/A | 306 | NA | extracorporeal membrane oxygenation, intra-aortic balloon pump | Xijing Hospital, The First Affiliated Hospital of Zhengzhou University, Bethune International Peace Hospital, Beijing Anzhen Hospital, The Second Affiliated Hospital of Harbin Medical University, The General Hospital of Northern Theater Command | Coronary Artery Disease, Heart Failure | 07/21 | 06/24 | | |
| Han, Ying |
NCT05345210: Vonoprazan Hp Dual or Triple Eradication Regimes |
|
|
| Recruiting | 4 | 500 | RoW | Vonoprazan Fumarate+Amoxycillin+Clarithromycin 14days (VAC14), Vonoprazan Fumarate+Amoxycillin 14days (VA14), Vonoprazan Fumarate+Amoxycillin 7days (VA7), Vonoprazan Fumarate+Tetracycline+Furazolidone 14days (VTF14), Vonoprazan Fumarate+Tetracycline+Furazolidone 7days (VTF7) | Xijing Hospital of Digestive Diseases | Helicobacter Pylori | 02/23 | 03/23 | | |
NCT06168214: Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication |
|
|
| Recruiting | 4 | 1404 | RoW | Rabeprazloe+bismuth+amoxicillin+clarithromycin, Vonoprazan+amoxicillin+clarithromycin 14 days, Vonoprazan+amoxicillin+clarithromycin 7 days, Vonoprazan+tetracycline+furazolidone 14 days, Vonoprazan+tetracycline+furazolidone 7 days, Vonoprazan+amoxicillin+furazolidone 7 days, Vonoprazan+amoxicillin+tetracycline 14 days, Vonoprazan+amoxicillin 7 days, Vonoprazan+amoxicillin 14 days | Xijing Hospital of Digestive Diseases | the Eradication Rates of Helicobacter Pylori | 11/24 | 12/24 | | |
| Completed | 4 | 108 | US | Moxifloxacin (Topical) | University of California, San Francisco | Antibiotic Resistance, Ocular Surface Microbiome, Gut Resistome | 08/23 | 06/24 | | |
NCT02823353: Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis |
|
|
| Completed | 3 | 117 | RoW | Fenofibrate, UDCA | Xijing Hospital of Digestive Diseases | Primary Biliary Cirrhosis | 05/22 | 06/22 | | |
NCT02823366: Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid |
|
|
| Recruiting | 3 | 104 | RoW | Fenofibrate, UDCA | Xijing Hospital of Digestive Diseases | Primary Biliary Cirrhosis | 12/23 | 12/23 | | |
SHINY, NCT06157502: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke |
|
|
| Recruiting | 3 | 1380 | RoW | Shuxuening Injection, Placebo | Beijing Tiantan Hospital | Ischemic Stroke, Acute | 06/25 | 12/26 | | |
TAPIS, NCT06316570: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke |
|
|
| Recruiting | 3 | 1380 | RoW | Early Dual Antiplatelet Therapy, Ticagrelor and Aspirin, Placebo, Placebo of Ticagrelor and Aspirin | Beijing Tiantan Hospital | Ischemic Stroke, Acute | 12/25 | 12/26 | | |
NCT05751967: Fenofibrate Combined with Ursodeoxycholic Acid in Subjects with Primary Biliary Cholangitis |
|
|
| Recruiting | 3 | 150 | RoW | Placebo Combined With Ursodeoxycholic Acid, UDCA 13-15mg/kg/d, Fenofibrate Combined With Ursodeoxycholic Acid | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis | 12/25 | 12/25 | | |
| Recruiting | 3 | 640 | Europe, Canada, US | Low Energy SLT, Standard Energy SLT | West Virginia University, University of Pittsburgh | Glaucoma and Ocular Hypertension | 06/27 | 08/27 | | |
NCT06365424: Fenofibrate in Patients with Primary Biliary Cholangitis (PBC) |
|
|
| Recruiting | 2/3 | 117 | RoW | Fenofibrate, UDCA | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis | 04/27 | 04/27 | | |
NCT06174402: Fenofibrate in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis |
|
|
| Recruiting | 2/3 | 184 | RoW | Fenofibrate, Placebo, UDCA | Han Ying | Primary Biliary Cholangitis | 12/25 | 12/25 | | |
NCT05749822: Fenofibrate for Compensated Cirrhosis Patients with Primary Biliary Cholangitis |
|
|
| Recruiting | 2/3 | 104 | RoW | Fenofibrate 200mg, Placebo, UDCA | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis | 12/25 | 12/25 | | |
NCT03370744: Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD |
|
|
| Completed | N/A | 300 | RoW | Neuropsychological scale | XuanwuH 2 | Subjective Cognitive Decline, Preclinical Alzheimer's Disease | 06/20 | 12/22 | | |
Pan-CHESS1801, NCT03778775: Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis |
|
|
| Recruiting | N/A | 200 | Japan, RoW | Liver sitffness measurement, Esophagogastroduodenoscopy | Nanfang Hospital of Southern Medical University, Beijing Tsinghua Changgeng Hospital, LanZhou University, Beijing 302 Hospital, Xijing Hospital of Digestive Diseases, Wuhan Union Hospital, China, Zhujiang Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, The Central Hospital of Lishui City, Xingtai People's Hospital, Seventh Medical Center of PLA Army General Hospital, Shandong Provincial Hospital, Shunde Hospital, Southern Medical University, Medistra Hospital, University of Indonesia, Ankara University, Osaka City University, Chulalongkorn University | Compensated Liver Cirrhosis, Gastroesophageal Varices Bleeding | 06/21 | 03/22 | | |
NCT05273385: Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma |
|
|
| Recruiting | N/A | 40 | US | Nanodropper | University of California, San Francisco, Nanodropper, Inc., Icare Finland Oy | Glaucoma, Ocular Hypertension, Open Angle Glaucoma | 12/24 | 12/24 | | |
| Recruiting | N/A | 800 | RoW | Multiple features extraction | XuanwuH 2, University of Cologne | Alzheimer Disease, Subjective Cognitive Decline, Neuroimaging, Gene | 12/24 | 12/25 | | |
NCT05606237: Efficacy of Repeated Low-level Red-light Therapy in Myopia Control |
|
|
| Recruiting | N/A | 90 | US | Low-level Red Light Therapy Device | University of California, San Francisco, University of Melbourne | Myopia | 07/25 | 07/25 | | |
| Recruiting | N/A | 226 | Canada, US | Sulcus tube placement, Anterior chamber (AC) tube placement | University of Pennsylvania, National Eye Institute (NEI), University of California, San Francisco, Stanford University | Glaucoma | 12/26 | 12/27 | | |
NCT05297006: Regulation and Mechanism of New Compound Functional Ingredients in Infants |
|
|
| Not yet recruiting | N/A | 180 | RoW | The infants who drank milk powder were given a dietary intervention four months before | Peking University Third Hospital, Peking University First Hospital, Peking University People's Hospital | Sialic Acid, Oligosaccharide | 10/22 | 12/22 | | |
| LU, Zhihong |
| Recruiting | N/A | 190 | RoW | remimazolam, propofol | Zhihong LU | General Anesthetic Drug Adverse Reaction | 01/24 | 01/24 | | |
| Recruiting | N/A | 68 | RoW | etomidate anesthesia, propofol anesthesia | Air Force Military Medical University, China | General Anesthesia | 12/22 | 02/23 | | |
| Recruiting | N/A | 20 | RoW | transcutaneous electrical acupoint stimulation, TEAS | Air Force Military Medical University, China | Sleep Disorder | 04/23 | 04/23 | | |
| Recruiting | N/A | 158 | RoW | transcutaneous electrical acupoint stimulation, TEAS | Zhihong LU | Cerebral Aneurysm | 06/23 | 06/23 | | |
| Not yet recruiting | N/A | 226 | RoW | transcutaneous electrical acupoint stimulation, TEAS, Control | Zhihong LU | Anesthesia, Postoperative Delirium, Electroencephalogram | 12/25 | 06/26 | | |
| Completed | N/A | 274 | RoW | transcutaneous electrical acupoint stimulation, TEAS | Air Force Military Medical University, China | Anesthesia, Sleep | 01/24 | 01/24 | | |
| Not yet recruiting | N/A | 50 | RoW | transcutaneous electrical acupoint stimulation | Zhihong LU | Cognition | 04/25 | 05/25 | | |
